PAVmed Statistics

Total Valuation

PAVmed has a market cap or net worth of $56.46 million. The enterprise value is $66.97 million.

Market Cap	56.46M
Enterprise Value	66.97M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

PAVmed has 6.32 million shares outstanding. The number of shares has decreased by -69.15% in one year.

Current Share Class	6.32M
Shares Outstanding	6.32M
Shares Change (YoY)	-69.15%
Shares Change (QoQ)	+24.60%
Owned by Insiders (%)	41.58%
Owned by Institutions (%)	3.32%
Float	2.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	782.75
Forward PS	111.19
PB Ratio	0.84
P/TBV Ratio	5.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	943.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17, with a Debt / Equity ratio of 0.60.

Current Ratio	0.17
Quick Ratio	0.13
Debt / Equity	0.60
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,038.38

Financial Efficiency

Return on equity (ROE) is -32.34% and return on invested capital (ROIC) is -45.07%.

Return on Equity (ROE)	-32.34%
Return on Assets (ROA)	-39.24%
Return on Invested Capital (ROIC)	-45.07%
Return on Capital Employed (ROCE)	-90.95%
Weighted Average Cost of Capital (WACC)	7.06%
Revenue Per Employee	$1,732
Profits Per Employee	-$92,049
Employee Count	41
Asset Turnover	0.00
Inventory Turnover	0.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.79% in the last 52 weeks. The beta is 0.81, so PAVmed's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-60.79%
50-Day Moving Average	9.74
200-Day Moving Average	11.47
Relative Strength Index (RSI)	44.45
Average Volume (20 Days)	12,097

Short Selling Information

The latest short interest is 15,238, so 0.24% of the outstanding shares have been sold short.

Short Interest	15,238
Short Previous Month	23,477
Short % of Shares Out	0.24%
Short % of Float	0.55%
Short Ratio (days to cover)	1.13

Income Statement

In the last 12 months, PAVmed had revenue of $71,000 and -$3.77 million in losses. Loss per share was -$5.63.

Revenue	71,000
Gross Profit	-147,000
Operating Income	-21.81M
Pretax Income	-2.47M
Net Income	-3.77M
EBITDA	-21.70M
EBIT	-21.81M
Loss Per Share	-$5.63

Full Income Statement

Balance Sheet

The company has $1.95 million in cash and $13.35 million in debt, giving a net cash position of -$11.40 million or -$1.80 per share.

Cash & Cash Equivalents	1.95M
Total Debt	13.35M
Net Cash	-11.40M
Net Cash Per Share	-$1.80
Equity (Book Value)	22.30M
Book Value Per Share	10.01
Working Capital	-12.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.21 million and capital expenditures -$31,000, giving a free cash flow of -$5.24 million.

Operating Cash Flow	-5.21M
Capital Expenditures	-31,000
Depreciation & Amortization	105,000
Net Borrowing	n/a
Free Cash Flow	-5.24M
FCF Per Share	-$0.83

Full Cash Flow Statement

Margins

Gross margin is -207.04%, with operating and profit margins of -30,712.68% and 564.79%.

Gross Margin	-207.04%
Operating Margin	-30,712.68%
Pretax Margin	-3,477.46%
Profit Margin	564.79%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PAVmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	69.15%
Shareholder Yield	69.15%
Earnings Yield	-6.79%
FCF Yield	-9.42%

Analyst Forecast

The average price target for PAVmed is $65.00, which is 627.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$65.00
Price Target Difference	627.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 2, 2026. It was a reverse split with a ratio of 1:30.

Last Split Date	Jan 2, 2026
Split Type	Reverse
Split Ratio	1:30

Scores

PAVmed has an Altman Z-Score of -11.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.21
Piotroski F-Score	1